FDA Inspection
Grifols Diagnostic Solutions Inc.Grifols Diagnostic Solutions Inc. – FDA Inspection, Dec 13, 2024
Record Details
This FDA Inspection record concerns Grifols Diagnostic Solutions Inc., with an inspection on December 13, 2024, issued by the San Francisco District Office, covering biologics.
View Company Profile
ID · 031425f6-3b06-40ef-a687-fbd072a4c73b
Inspection Facts
- Inspection number
- 1258104
- FDA center
- Biologics
Other FDA inspections of Grifols Diagnostic Solutions Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| October 31, 2025 | VAI | San Francisco District Office | Blood and Blood Products |
| December 7, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 15, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 28, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 29, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Diagnostic Solutions Inc.
- FDA Inspection 1289592 - 2025-10-31
- FDA Inspection 1162064 - 2021-12-07
- FDA Inspection 1079880 - 2019-02-15
- FDA Inspection 991586 - 2016-09-28
- FDA Inspection 894326 - 2014-01-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.